BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20938978)

  • 1. Conformational regulation of the EGFR kinase core by the juxtamembrane and C-terminal tail: a molecular dynamics study.
    Mustafa M; Mirza A; Kannan N
    Proteins; 2011 Jan; 79(1):99-114. PubMed ID: 20938978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational dynamics of the EGFR kinase domain reveals structural features involved in activation.
    Papakyriakou A; Vourloumis D; Tzortzatou-Stathopoulou F; Karpusas M
    Proteins; 2009 Aug; 76(2):375-86. PubMed ID: 19173306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of Thr654 but not Thr669 within the juxtamembrane domain of the EGF receptor inhibits calmodulin binding.
    Aifa S; Frikha F; Miled N; Johansen K; Lundström I; Svensson SP
    Biochem Biophys Res Commun; 2006 Aug; 347(2):381-7. PubMed ID: 16793002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A basic peptide within the juxtamembrane region is required for EGF receptor dimerization.
    Aifa S; Aydin J; Nordvall G; Lundström I; Svensson SP; Hermanson O
    Exp Cell Res; 2005 Jan; 302(1):108-14. PubMed ID: 15541730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrostatic interactions of peptides flanking the tyrosine kinase domain in the epidermal growth factor receptor provides a model for intracellular dimerization and autophosphorylation.
    Aifa S; Miled N; Frikha F; Aniba MR; Svensson SP; Rebai A
    Proteins; 2006 Mar; 62(4):1036-43. PubMed ID: 16380971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the membrane reconstituted transmembrane-juxtamembrane peptide EGFR(622-660) and its interaction with Ca2+/calmodulin.
    Sato T; Pallavi P; Golebiewska U; McLaughlin S; Smith SO
    Biochemistry; 2006 Oct; 45(42):12704-14. PubMed ID: 17042488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor.
    Zhang X; Gureasko J; Shen K; Cole PA; Kuriyan J
    Cell; 2006 Jun; 125(6):1137-49. PubMed ID: 16777603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of EGF receptor C-terminal sequences 1005-1017 and di-leucine motif 1010LL1011 as essential in EGF receptor endocytosis.
    Wang Q; Zhu F; Wang Z
    Exp Cell Res; 2007 Sep; 313(15):3349-63. PubMed ID: 17643422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detailed conformational dynamics of juxtamembrane region and activation loop in c-Kit kinase activation process.
    Zou J; Wang YD; Ma FX; Xiang ML; Shi B; Wei YQ; Yang SY
    Proteins; 2008 Jul; 72(1):323-32. PubMed ID: 18214972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
    Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
    Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-conserved features associated with cis regulation of ErbB tyrosine kinases.
    Mirza A; Mustafa M; Talevich E; Kannan N
    PLoS One; 2010 Dec; 5(12):e14310. PubMed ID: 21179209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the epidermal growth factor receptor: a series of twists and turns.
    Poger D; Mark AE
    Biochemistry; 2014 Apr; 53(16):2710-21. PubMed ID: 24697572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics of the asymmetric dimers of EGFR: simulations on the active and inactive conformations of the kinase domain.
    Songtawee N; Bevan DR; Choowongkomon K
    J Mol Graph Model; 2015 May; 58():16-29. PubMed ID: 25805329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A putative mechanism for downregulation of the catalytic activity of the EGF receptor via direct contact between its kinase and C-terminal domains.
    Landau M; Fleishman SJ; Ben-Tal N
    Structure; 2004 Dec; 12(12):2265-75. PubMed ID: 15576039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-protein interactions in the allosteric regulation of protein kinases.
    Pellicena P; Kuriyan J
    Curr Opin Struct Biol; 2006 Dec; 16(6):702-9. PubMed ID: 17079130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation mechanism of solubilized epidermal growth factor receptor tyrosine kinase.
    Ge G; Wu J; Wang Y; Lin Q
    Biochem Biophys Res Commun; 2002 Jan; 290(3):914-20. PubMed ID: 11798160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics simulation reveals structural and thermodynamic features of kinase activation by cancer mutations within the epidermal growth factor receptor.
    Wan S; Coveney PV
    J Comput Chem; 2011 Oct; 32(13):2843-52. PubMed ID: 21717480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the protein tyrosine kinase activity and autophosphorylation of the epidermal growth factor receptor by its juxtamembrane region.
    Poppleton HM; Wiepz GJ; Bertics PJ; Patel TB
    Arch Biochem Biophys; 1999 Mar; 363(2):227-36. PubMed ID: 10068444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p38γ activation triggers dynamical changes in allosteric docking sites.
    Rodriguez Limardo RG; Ferreiro DN; Roitberg AE; Marti MA; Turjanski AG
    Biochemistry; 2011 Mar; 50(8):1384-95. PubMed ID: 21235211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
    Chen L; Rydel TJ; Gu F; Dunaway CM; Pikul S; Dunham KM; Barnett BL
    J Mol Biol; 1999 Oct; 293(3):545-57. PubMed ID: 10543949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.